128 related articles for article (PubMed ID: 38285769)
1. Impact of Anti-nuclear Antibody Seropositivity on Clinicopathological Parameters, Treatment Response, and Survival in Lymphoma Patients.
Kumar M; Prakash G; Bal A; Kumari A; Kumar Y; Bhardwaj R; Malhotra P; Minz RW
Asian Pac J Cancer Prev; 2024 Jan; 25(1):73-78. PubMed ID: 38285769
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
[TBL] [Abstract][Full Text] [Related]
3. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases.
Mariz HA; Sato EI; Barbosa SH; Rodrigues SH; Dellavance A; Andrade LE
Arthritis Rheum; 2011 Jan; 63(1):191-200. PubMed ID: 20954189
[TBL] [Abstract][Full Text] [Related]
4. [Application of Antinuclear Antibody and Antinuclear Antibody Spectrum in Lymphoma Treatment].
Wang ME; Fan CM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):861-865. PubMed ID: 32552948
[TBL] [Abstract][Full Text] [Related]
5. Uncommon antinuclear antibody patterns as diagnostic indicators.
Nanda R; Gupta P; Patel S; Shah S; Mohapatra E
Clin Biochem; 2021 Apr; 90():28-33. PubMed ID: 33539810
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of elevated antinuclear antibody test in patients with Hodgkin's and Non-Hodgkin's lymphoma: a single center experience.
Altintas A; Cil T; Pasa S; Danis R; Kilinc I; Ayyildiz O; Muftuoglu E
Minerva Med; 2008 Feb; 99(1):7-14. PubMed ID: 18299692
[TBL] [Abstract][Full Text] [Related]
7. Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders.
Gulli F; Basile U; Gragnani L; Fognani E; Napodano C; Colacicco L; Miele L; De Matthaeis N; Cattani P; Zignego AL; Rapaccini GL
Dig Liver Dis; 2016 Aug; 48(8):927-33. PubMed ID: 27289333
[TBL] [Abstract][Full Text] [Related]
8. The antinuclear antibody dense fine speckled pattern and possible clinical associations: An indication of a proinflammatory microenvironment.
Lundgren MC; Sapkota S; Peterson DJ; Crosson JT
J Immunol Methods; 2021 Jan; 488():112904. PubMed ID: 33121975
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD).
Seelig CA; Bauer O; Seelig HP
Clin Lab; 2016; 62(4):499-517. PubMed ID: 27215068
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of antinuclear antibodies in chronic hepatitis B patients].
Şener AG; Aydın N; Ceylan C; Kırdar S
Mikrobiyol Bul; 2018 Oct; 52(4):425-430. PubMed ID: 30522427
[TBL] [Abstract][Full Text] [Related]
11. Differences in the Clinical Significance of Antinuclear Antibodies According to Titers and Patterns in Children.
Park MJ; Jang HM; Kim D; Won DI; Baek HS; Cho MH
Clin Pediatr (Phila); 2023 Oct; 62(10):1254-1260. PubMed ID: 36829288
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of elevated antinuclear antibodies in patients with diffuse large B-cell lymphoma: A single center study.
Lang J; Ma K; Guo J; Zhang J; Wang Q; Sun H
J Cancer Res Ther; 2018 Jan; 14(1):213-219. PubMed ID: 29516988
[TBL] [Abstract][Full Text] [Related]
13. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay.
Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H
Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases.
Marin GG; Cardiel MH; Cornejo H; Viveros ME
J Clin Rheumatol; 2009 Oct; 15(7):325-9. PubMed ID: 20009966
[TBL] [Abstract][Full Text] [Related]
15. Cellular aging over 13 years associated with incident antinuclear antibody positivity in the Baltimore Longitudinal Study of Aging.
Meier HCS; Parks CG; Liu HB; Sandler DP; Simonsick EM; Deane K; Weng NP
J Autoimmun; 2019 Dec; 105():102295. PubMed ID: 31303354
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of anti-DFS70 for identifying antinuclear antibody-positive patients without systemic autoimmune rheumatic disease.
Tan TC; Ng CYL; Leong KP
Singapore Med J; 2022 Mar; 63(3):147-151. PubMed ID: 32798356
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of antinuclear antibodies in children with thyroid autoimmunity.
Segni M; Pucarelli I; Truglia S; Turriziani I; Serafinelli C; Conti F
J Immunol Res; 2014; 2014():150239. PubMed ID: 24741574
[TBL] [Abstract][Full Text] [Related]
18. ANA-specific antibodies, ANA patterns, anti-ds-DNA results, and clinical diagnosis: a laboratory and clinical audit.
Anis S; Fatima A; Abdul Jabbar S; Arain T
Immunol Res; 2023 Apr; 71(2):267-275. PubMed ID: 36456720
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of unidentified precipitin lines (UPLs) in immune precipitation assays.
Pajaro A; Nikoloutsopoulos T; Roberts-Thomson P
Pathology; 2015 Jan; 47(1):62-7. PubMed ID: 25474508
[TBL] [Abstract][Full Text] [Related]
20. Serum autoantibodies positivity prevalence in patients with chronic HCV and impact on pegylated interferon and ribavirin treatment response.
Khairy M; El-Raziky M; El-Akel W; Abdelbary MS; Khatab H; El-Kholy B; Esmat G; Mabrouk M
Liver Int; 2013 Nov; 33(10):1504-9. PubMed ID: 23763380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
